Fineotex Chemical Ltd
Incorporated in 1979, Fineotex Chemicals Ltd is engaged in the business of manufacturing auxiliaries and specialty chemicals for textiles, construction, water treatment, fertilizer, leather, and paint industries[1]
- Market Cap ₹ 3,623 Cr.
- Current Price ₹ 324
- High / Low ₹ 459 / 304
- Stock P/E 31.8
- Book Value ₹ 52.8
- Dividend Yield 0.48 %
- ROCE 44.2 %
- ROE 35.2 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 45.1% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 27.2%
- Company's median sales growth is 18.2% of last 10 years
- Company's working capital requirements have reduced from 109 days to 83.0 days
Cons
- Promoter holding has decreased over last quarter: -1.58%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE Allcap BSE Commodities Nifty Microcap 250 Nifty Total Market BSE SmallCap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
41 | 53 | 65 | 68 | 75 | 90 | 113 | 129 | 129 | 250 | 296 | 419 | 448 | |
35 | 50 | 54 | 50 | 56 | 66 | 87 | 101 | 98 | 197 | 235 | 305 | 329 | |
Operating Profit | 5 | 4 | 11 | 19 | 19 | 24 | 25 | 28 | 31 | 53 | 61 | 113 | 119 |
OPM % | 13% | 7% | 17% | 27% | 25% | 26% | 22% | 22% | 24% | 21% | 21% | 27% | 27% |
2 | 5 | 5 | 4 | 10 | 8 | 1 | -9 | 16 | 6 | 11 | 32 | 33 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 5 | 6 |
Profit before tax | 7 | 8 | 15 | 22 | 28 | 30 | 25 | 17 | 45 | 57 | 68 | 141 | 146 |
Tax % | 26% | 28% | 27% | 31% | 24% | 29% | 31% | 37% | 20% | 23% | 23% | 21% | |
5 | 6 | 11 | 15 | 21 | 21 | 17 | 11 | 36 | 44 | 52 | 111 | 114 | |
EPS in Rs | 0.48 | 0.52 | 1.00 | 1.35 | 1.90 | 1.91 | 1.56 | 0.97 | 3.25 | 3.97 | 4.70 | 9.99 | 10.24 |
Dividend Payout % | 10% | 10% | 10% | 15% | 5% | 10% | 6% | 5% | 9% | 10% | 17% | 16% |
Compounded Sales Growth | |
---|---|
10 Years: | 23% |
5 Years: | 30% |
3 Years: | 48% |
TTM: | 28% |
Compounded Profit Growth | |
---|---|
10 Years: | 37% |
5 Years: | 45% |
3 Years: | 45% |
TTM: | 45% |
Stock Price CAGR | |
---|---|
10 Years: | 32% |
5 Years: | 65% |
3 Years: | 43% |
1 Year: | 5% |
Return on Equity | |
---|---|
10 Years: | 22% |
5 Years: | 24% |
3 Years: | 27% |
Last Year: | 35% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 11 | 11 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 23 |
Reserves | 43 | 49 | 48 | 61 | 80 | 99 | 116 | 125 | 159 | 200 | 247 | 336 | 567 |
6 | 4 | 2 | 3 | 1 | 5 | 2 | 3 | 3 | 2 | 7 | 5 | 0 | |
8 | 12 | 12 | 10 | 12 | 14 | 19 | 21 | 28 | 47 | 46 | 68 | 55 | |
Total Liabilities | 69 | 76 | 85 | 97 | 115 | 139 | 159 | 171 | 213 | 271 | 323 | 431 | 645 |
6 | 7 | 11 | 12 | 20 | 22 | 28 | 33 | 52 | 67 | 81 | 90 | 122 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
Investments | 29 | 25 | 39 | 48 | 56 | 64 | 58 | 62 | 43 | 28 | 76 | 149 | 300 |
33 | 44 | 36 | 37 | 39 | 54 | 73 | 76 | 115 | 176 | 165 | 193 | 223 | |
Total Assets | 69 | 76 | 85 | 97 | 115 | 139 | 159 | 171 | 213 | 271 | 323 | 431 | 645 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | -1 | 8 | 9 | 11 | 9 | 3 | 22 | -1 | 13 | 66 | 69 | |
2 | 5 | -5 | -6 | -5 | -8 | 4 | -17 | -6 | 7 | -69 | -11 | |
-3 | -4 | -3 | -2 | -6 | -2 | -1 | -2 | -3 | -4 | -5 | -23 | |
Net Cash Flow | 0 | 0 | 1 | 1 | -1 | -2 | 6 | 3 | -10 | 17 | -7 | 35 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 102 | 117 | 95 | 102 | 98 | 90 | 112 | 111 | 163 | 110 | 90 | 95 |
Inventory Days | 52 | 55 | 40 | 54 | 71 | 97 | 86 | 68 | 121 | 127 | 80 | 58 |
Days Payable | 89 | 102 | 80 | 91 | 109 | 92 | 93 | 94 | 133 | 109 | 85 | 91 |
Cash Conversion Cycle | 65 | 69 | 54 | 64 | 60 | 94 | 105 | 85 | 152 | 128 | 86 | 61 |
Working Capital Days | 52 | 86 | 60 | 86 | 84 | 124 | 145 | 128 | 198 | 145 | 99 | 83 |
ROCE % | 11% | 11% | 17% | 27% | 30% | 27% | 19% | 21% | 27% | 28% | 27% | 44% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
15 Nov - Audio recording of Q2 FY2024-2025 investor call available.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - Newspaper Advertisement for Unaudited Financial Results for quarter ended September 30, 2024
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
14 Nov - Monitoring Agency Report for Q2 2024 submitted.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
14 Nov - Monitoring Agency Report for Q3 2024 issued.
-
Statement Of Deviation And Variation For The Quarter Ended September 30, 2024
14 Nov - Statement confirming no deviation in fund utilization.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024TranscriptNotesPPT
-
Aug 2024Transcript PPT REC
-
Aug 2024TranscriptNotesPPT
-
Jun 2024Transcript PPT
-
May 2024TranscriptNotesPPT
-
Mar 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Nov 2023TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
Jun 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Apr 2022TranscriptNotesPPT
-
Jan 2022Transcript PPT
-
Jan 2022TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Nov 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
Jul 2021TranscriptNotesPPT
-
May 2021Transcript PPT
-
Apr 2021TranscriptNotesPPT
-
Feb 2021Transcript PPT
-
Jan 2021TranscriptNotesPPT
-
Jan 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Sep 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
Aug 2018Transcript PPT
-
Aug 2018TranscriptNotesPPT
-
Jun 2018Transcript PPT
-
Jun 2018TranscriptNotesPPT
-
Jun 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Dec 2017TranscriptNotesPPT
-
Dec 2017TranscriptNotesPPT
-
Sep 2017TranscriptNotesPPT
-
Sep 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
Mar 2017Transcript PPT
-
Feb 2017TranscriptNotesPPT
-
Nov 2016Transcript PPT
-
Nov 2016TranscriptNotesPPT
-
Aug 2016Transcript PPT
-
Aug 2016TranscriptNotesPPT
-
May 2016Transcript PPT
-
Mar 2016TranscriptNotesPPT
-
Mar 2016TranscriptNotesPPT
-
Feb 2016TranscriptNotesPPT
-
Nov 2015TranscriptNotesPPT
-
Aug 2015TranscriptNotesPPT
Business Segments[1]
Textile Chemical segment: Specialty chemicals producer with a focus on textiles
chemicals. Biotex Malaysia spearheads the R&D solutions, application research and product development.
Cleaning and Hygiene segment: Products such as floor cleaners, hand-washes, sanitizers, dishwashers, and toilet bowl cleaners are manufactured. The company offers customised solutions.